Conning Inc. Edwards Lifesciences Corp Transaction History

Conning Inc.

$2.67 Billion
Q2 2024

A detailed history of Conning Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Conning Inc. holds 4,769 shares of EW stock, worth $326,771. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,769

Previous 4,491 6.19%

Holding current value

$326,771

Previous $429,000 2.56%

% of portfolio

0.02%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$84.3 - $94.31 $23,435 - $26,218	278 Added 6.19%	4,769 $440,000
Q1 2024 Apr 26, 2024	SELL	$72.54 - $95.56 $13,057 - $17,200	-180 Reduced 3.85%	4,491 $429,000
Q4 2023 Jan 29, 2024	BUY	$61.71 - $77.76 $1,851 - $2,332	30 Added 0.65%	4,671 $356,000
Q3 2023 Oct 26, 2023	SELL	$69.28 - $93.38 $5,542 - $7,470	-80 Reduced 1.69%	4,641 $321,000
Q2 2023 Jul 21, 2023	SELL	$81.41 - $94.33 $35,006 - $40,561	-430 Reduced 8.35%	4,721 $445,000
Q1 2023 Apr 27, 2023	SELL	$74.26 - $84.51 $2,747 - $3,126	-37 Reduced 0.71%	5,151 $426,000
Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $1,024 - $1,311	-15 Reduced 0.29%	5,188 $387,000
Q3 2022 Oct 28, 2022	SELL	$82.37 - $107.29 $76,192 - $99,243	-925 Reduced 15.09%	5,203 $430,000
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $4,411 - $6,541	-51 Reduced 0.83%	6,128 $583,000
Q1 2022 May 02, 2022	SELL	$101.96 - $128.34 $20,392 - $25,668	-200 Reduced 3.14%	6,179 $727,000
Q4 2021 Jan 27, 2022	SELL	$106.37 - $130.68 $638,858 - $784,864	-6,006 Reduced 48.49%	6,379 $826,000
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $468,755 - $559,126	4,555 Added 58.17%	12,385 $1.4 Million
Q2 2021 Jul 29, 2021	SELL	$83.84 - $104.76 $61,706 - $77,103	-736 Reduced 8.59%	7,830 $811,000
Q1 2021 Apr 23, 2021	SELL	$78.68 - $90.67 $56,649 - $65,282	-720 Reduced 7.75%	8,566 $716,000
Q4 2020 Jan 28, 2021	SELL	$71.69 - $91.23 $32,905 - $41,874	-459 Reduced 4.71%	9,286 $847,000
Q3 2020 Oct 21, 2020	BUY	$67.19 - $87.44 $8,129 - $10,580	121 Added 1.26%	9,745 $778,000
Q2 2020 Aug 07, 2020	BUY	$57.54 - $76.95 $357,898 - $478,629	6,220 Added 182.73%	9,624 $665,000
Q1 2020 Apr 29, 2020	SELL	$52.41 - $81.0 $104 - $162	-2 Reduced 0.06%	3,404 $642,000
Q4 2019 Jan 29, 2020	SELL	$71.7 - $82.09 $9,321 - $10,671	-130 Reduced 3.68%	3,406 $795,000
Q3 2019 Oct 30, 2019	BUY	$61.55 - $75.43 $6,770 - $8,297	110 Added 3.21%	3,536 $778,000
Q2 2019 Jul 25, 2019	SELL	$55.74 - $64.41 $32,886 - $38,001	-590 Reduced 14.69%	3,426 $633,000
Q1 2019 Apr 22, 2019	SELL	$47.89 - $64.05 $478 - $640	-10 Reduced 0.25%	4,016 $768,000
Q4 2018 Jan 29, 2019	SELL	$46.41 - $56.94 $23,205 - $28,470	-500 Reduced 11.05%	4,026 $617,000
Q3 2018 Oct 26, 2018	SELL	$45.7 - $58.03 $13,253 - $16,828	-290 Reduced 6.02%	4,526 $788,000
Q2 2018 Jul 25, 2018	SELL	$42.45 - $51.3 $8,914 - $10,773	-210 Reduced 4.18%	4,816 $701,000
Q1 2018 May 04, 2018	SELL	$37.19 - $47.45 $371 - $474	-10 Reduced 0.2%	5,026 $701,000
Q4 2017 Jan 30, 2018	SELL	$33.79 - $39.39 $2,703 - $3,151	-80 Reduced 1.56%	5,036 $568,000
Q3 2017 Oct 20, 2017	BUY	$36.29 - $38.83 $185,659 - $198,654	5,116	5,116 $559,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account